Favorable outcome of allogeneic hematopoietic stem cell transplantation followed by post-transplant treatment with imatinib in children with Philadelphia chromosome-positive acute lymphoblastic leukemia

BACKGROUND: Allogeneic hematopoietic stem cell transplantation (HSCT) is the preferred curative therapy for children with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL). We evaluated the treatment outcomes of children with Ph+ ALL who underwent allogeneic HSCT. METHODS: Fi...

Descripción completa

Detalles Bibliográficos
Autores principales: Byun, Ye Jee, Suh, Jin Kyung, Lee, Seong Wook, Lee, Darae, Kim, Hyunjin, Choi, Eun Seok, Koh, Kyung-Nam, Im, Ho Joon, Seo, Jong Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4595580/
https://www.ncbi.nlm.nih.gov/pubmed/26457281
http://dx.doi.org/10.5045/br.2015.50.3.147

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4595580/
https://www.ncbi.nlm.nih.gov/pubmed/26457281
http://dx.doi.org/10.5045/br.2015.50.3.147

Ejemplares similares